RE:RE:RE:RE:RE:No comments?
While it may not immediately reflect in share price, this is a VERY big news release. To suggest otherwise ignores several major concerns with this company. All that TTT had leading up to this point, essentially, was WeedMD - and the WeedMD investment was only secured because of Cameron Chell s relationship with Michael Kraft. It doesnt take much research to find the regularity of Chells failed start ups and shady dealings. Despite having spoken with TTT and understanding the limited role that Chell plays in the company, I have been very concerned with the future of TTT. Now, assuming the pilot is successful, the validation that Shoppers provides is a game changer. Not only does it demonstrate that TTT has the product and personnel to align with Shoppers stringent processes and system architecture (and the inherent global recognition!), but it opens the door to several major global players as well as the laboratories that they use. All LPs selling through Shoppers will need to be integrated with Secure Strain. Simply put, a deal with Shoppers put TTT in the global conversation. This SP will be held back until revenues start to roll in. With their current cash position, a raise is still very possible. To say it is not a big news release is to say that it doesnt matter if this pilot fails and TTT ends up losing Shoppers. This is bigtime and I really hope the pilot is a success.